Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers is a research paper published in Translational Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of General Medical Sciences
Grant: 1R35GM119839\u201301
National Institute of General Medical Sciences
Grant: 1R35GM119839-01
Synergistic combination of nanotechnology and radiation in medicine
NIGMS NIH HHS
Grant: R35 GM119839
American Foundation for Pharmaceutical Education
PhRMA Foundation
Oregon State University
National Institutes of Health
FWCI
1.30
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals